Montelukast
Product Images NDC 54458-890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 54458-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by International Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error† Of The Mean) (Montelukast Sodium 1)

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error† Of The Mean) (Montelukast Sodium 1)
A line graph showing change in height (cm) over weeks on treatment for three groups: Montelukast 5 mg, Beclomethasone 336 mcg, and placebo. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. Each treatment group is represented by a different line style as indicated in the legend.*
FDA Label Image

Chemical Structure (Montelukast Sodium 2)

Chemical Structure (Montelukast Sodium 2)
Chemical structure of Montelukast, depicting its molecular arrangement with specific atoms and bonds, including chlorine, sulfur, and sodium carboxylate groups.*
FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error† Of The Mean) (Montelukast Sodium 3)

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error† Of The Mean) (Montelukast Sodium 3)
A line chart comparing mean percent change from baseline over weeks in treatment between Montelukast Sodium and placebo groups. The x-axis shows weeks of treatment from 0 to 15, and the y-axis shows mean percent change from baseline. Montelukast group data points rise sharply and plateau, while placebo group shows smaller increases. A washout period is indicated from weeks 12 to 15.*
FDA Label Image

Montelukast Sodium Tablets 10 mg (Montelukast Sodium 4)

Montelukast Sodium Tablets 10 mg (Montelukast Sodium 4)
Montelukast Sodium 10 mg tablets packaging label from International Laboratories, LLC. The label states the medication is for patients 15 years and older and includes instructions to press and hold a button to open the card containing 30 tablets. The product is marked Rx only and highlights child-resistant packaging. The label also shows the Walmart logo and notes the tablets contain 10.4 mg montelukast sodium equivalent to 10 mg montelukast. Additional details include storage conditions and packaging benefits such as protection of each pill and recyclability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.